Hartford Funds Management Co LLC reduced its stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 32.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,863 shares of the company’s stock after selling 1,861 shares during the period. Hartford Funds Management Co LLC’s holdings in HCA Healthcare were worth $1,650,000 as of its most recent SEC filing.
Other hedge funds have also bought and sold shares of the company. Sunbelt Securities Inc. boosted its stake in shares of HCA Healthcare by 171.7% during the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock worth $2,954,000 after acquiring an additional 3,945 shares in the last quarter. Sei Investments Co. raised its stake in shares of HCA Healthcare by 27.5% in the 1st quarter. Sei Investments Co. now owns 467,796 shares of the company’s stock valued at $221,380,000 after acquiring an additional 100,764 shares in the last quarter. Darsana Capital Partners LP raised its stake in shares of HCA Healthcare by 46.7% in the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after acquiring an additional 350,000 shares in the last quarter. Ulrich Consultants & Investment Group LLC acquired a new stake in HCA Healthcare in the 3rd quarter worth approximately $2,054,000. Finally, Fund 1 Investments LLC bought a new stake in HCA Healthcare during the second quarter worth approximately $975,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.
HCA Healthcare Stock Down 5.1%
Shares of NYSE HCA opened at $475.84 on Thursday. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The company has a market cap of $99.40 billion, a P/E ratio of 15.77, a P/E/G ratio of 1.67 and a beta of 1.11. The business’s 50 day moving average is $457.97 and its two-hundred day moving average is $446.05.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share for the quarter, beating the consensus estimate of $6.65 by $0.57. The company had revenue of $19.85 billion during the quarter, compared to analysts’ expectations of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. HCA Healthcare’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period in the prior year, the business earned $6.96 earnings per share. Sell-side analysts expect that HCA Healthcare, Inc. will post 30.14 earnings per share for the current fiscal year.
HCA Healthcare Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be issued a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is 10.34%.
Analysts Set New Price Targets
Several equities analysts have commented on HCA shares. Barclays increased their price target on HCA Healthcare from $387.00 to $401.00 and gave the company an “equal weight” rating in a report on Thursday, October 29th. TD Cowen upped their price objective on shares of HCA Healthcare from $460.00 to $486.00 and gave the stock a “buy” rating in a report on Wednesday, October 28th. Mizuho set a $495.00 target price on shares of HCA Healthcare in a research note on Wednesday, October 28th. BMO Capital Markets began coverage on shares of HCA Healthcare in a report on Tuesday, September 22nd. They issued an “outperform” rating and a $495.00 target price on the stock. Finally, Royal Bank Of Canada boosted their target price on shares of HCA Healthcare from $496.00 to $521.00 and gave the stock an “outperform” rating in a research report on Friday, October 30th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $482.30.
Get Our Latest Stock Report on HCA Healthcare
Insider Buying and Selling at HCA Healthcare
In other news, SVP Erica Rossitto sold 3,500 shares of the company’s stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $505.81, for a total transaction of $1,770,335.00. Following the completion of the transaction, the senior vice president owned 13,426 shares of the company’s stock, valued at approximately $6,791,005.06. This represents a 20.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Jon M. Foster sold 21,713 shares of the stock in a transaction dated Friday, November 6th. The shares were sold at an average price of $494.95, for a total transaction of $10,746,849.35. Following the completion of the sale, the chief operating officer owned 10,000 shares of the company’s stock, valued at approximately $4,949,500. The trade was a 68.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 36,413 shares of company stock valued at $18,251,464 in the last ninety days. Company insiders own 1.50% of the company’s stock.
HCA Healthcare Profile
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
Read More
- Five stocks we like better than HCA Healthcare
- From Berlin to Brussels: Tesla’s $3.3 Billion Robotaxi Gamble
- Target Stock Is Up Over 70%—Has the Easy Money Already Been Made?
- Amazon’s Zoox Just Joined Uber—Could That Change the Robotaxi Threat?
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
